Cellebrite Stock Financials

CLBT
 Stock
  

USD 4.54  0.10  2.16%   

Please use analysis of Cellebrite Di fundamentals to determine if markets are correctly pricing the company. We have analyzed twenty-eight available fundamental indicators for Cellebrite Di, which can be compared to its rivals. To ensure the equity is not overpriced, please confirm all Cellebrite Di financials, including its ebitda, and the relationship between the price to earning and book value per share . Given that Cellebrite Di has a shares owned by insiders of 76.86 %, we suggest you to validate Cellebrite Di prevailing market performance to make sure the company can sustain itself down the road. Use Cellebrite to protect your portfolios against small market fluctuations. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Cellebrite to be traded at $4.36 in 90 days.
  
With this module, you can analyze Cellebrite financials for your investing period. You should be able to track the changes in Cellebrite individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

Cellebrite Most Recent Estimates

Quarterly Earnings Growth YOY
1.6
EPS Estimate Next Quarter
0.04
Diluted Eps
0.9
EPS Estimate Current Year
0.06
EPS Estimate Next Year
0.16
EPS Estimate Current Quarter
0.02
Understanding current and past Cellebrite Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cellebrite's financial statements are interrelated, with each one affecting the others. For example, an increase in Cellebrite's assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Over 77
Cellebrite Di has more than 77 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Cellebrite stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Cellebrite's official financial statements usually reflect Cellebrite's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Cellebrite Di. For example, before you start analyzing numbers published by Cellebrite accountants, it's critical to develop an understanding of what Cellebrite's liquidity, profitability, and earnings quality are in the context of the Technology space in which it operates.
Please note, the presentation of Cellebrite's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cellebrite's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Cellebrite's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cellebrite Di. Please utilize our Beneish M Score to check the likelihood of Cellebrite's management to manipulate its earnings.

Cellebrite Company Summary

Cellebrite competes with Microsoft Corp, Oracle, Adobe Systems, Vmware, and Synopsys. Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation. Cellebrite operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 900 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
Business Address94 Shlomo Shmelzer
SectorTechnology
IndustrySoftware—Infrastructure
BenchmarkDOW
Websitewww.cellebrite.com
Phone972 73 394 8000
CurrencyUSD - US Dollar
You should never invest in Cellebrite without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Cellebrite Stock, because this is throwing your money away. Analyzing the key information contained in Cellebrite's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Cellebrite Key Financial Ratios

Generally speaking, Cellebrite's financial ratios allow both analysts and investors to convert raw data from Cellebrite's financial statements into concise, actionable information that can be used to evaluate the performance of Cellebrite over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Cellebrite Di reports annually and quarterly.

Cellebrite Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cellebrite's current stock value. Our valuation model uses many indicators to compare Cellebrite value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cellebrite competition to find correlations between indicators driving Cellebrite's intrinsic value. More Info.
Cellebrite Di is rated second in beta category among related companies. It is rated below average in cash and equivalents category among related companies creating about  119,138,211  of Cash and Equivalents per Beta. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cellebrite by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cellebrite's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cellebrite's earnings, one of the primary drivers of an investment's value.

Cellebrite Di Systematic Risk

Cellebrite's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cellebrite volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Cellebrite Di correlated with the market. If Beta is less than 0 Cellebrite generally moves in the opposite direction as compared to the market. If Cellebrite Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cellebrite Di is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cellebrite is generally in the same direction as the market. If Beta > 1 Cellebrite moves generally in the same direction as, but more than the movement of the benchmark.
.

About Cellebrite Financials

What exactly are Cellebrite Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Cellebrite's income statement, its balance sheet, and the statement of cash flows. Potential Cellebrite investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Cellebrite investors may use each financial statement separately, they are all related. The changes in Cellebrite's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cellebrite's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Cellebrite is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Cellebrite has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Cellebrite November 28, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Cellebrite help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cellebrite Di. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cellebrite Di based on widely used predictive technical indicators. In general, we focus on analyzing Cellebrite Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cellebrite's daily price indicators and compare them against related drivers.
Information Ratio(0.04023)
Maximum Drawdown11.53
Value At Risk(4.43)
Potential Upside4.12
Continue to Trending Equities. Note that the Cellebrite Di information on this page should be used as a complementary analysis to other Cellebrite's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Cellebrite Stock analysis

When running Cellebrite Di price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Is Cellebrite's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cellebrite. If investors know Cellebrite will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cellebrite listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
1.6
Market Capitalization
879 M
Quarterly Revenue Growth YOY
0.088
Return On Assets
(0.0081) 
Return On Equity
1.47
The market value of Cellebrite Di is measured differently than its book value, which is the value of Cellebrite that is recorded on the company's balance sheet. Investors also form their own opinion of Cellebrite's value that differs from its market value or its book value, called intrinsic value, which is Cellebrite's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cellebrite's market value can be influenced by many factors that don't directly affect Cellebrite's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cellebrite's value and its price as these two are different measures arrived at by different means. Investors typically determine Cellebrite value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cellebrite's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.